Lyra Health vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Leading mental health benefits platform for employers. Founded 2015 by ex-Facebook CFO. $5.58B valuation, $915M total funding. Serves 20M+ people through employer contracts.
About
Lyra Health is a workforce mental health platform founded in 2015 by David Ebersman (former CFO of Facebook/Meta) and Dena Bravata, headquartered in Burlingame, California. It provides AI-powered mental health benefits to employers through therapy, coaching, preventive care, specialized programs (substance use, DBT), and the Empower AI platform for personalized support.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.